Elidel, Protopic May Increase Cancer Risk

Safety labeling revisions for pimecrolimus and tacrolimus address potential risks for lymphoma and skin malignancies, according to the FDA.Yael Waknine

Continue to Elidel, Protopic May Increase Cancer Risk on Medscape Headlines.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz